Knoxville Biz Ticker: Knoxville Entrepreneur Center launches Made for Knoxville campaign
The Knoxville News-Sentinel 3 hrs ago Knoxville News Sentinel
Knoxville Entrepreneur Center launches Made for Knoxville campaign
“Made for Knoxville” is a print and social media campaign and storytelling website initiated by the Knoxville Entrepreneur Center to elevate awareness of Knoxville’s diverse entrepreneurial ecosystem ranging from “solo-preneurs,” makers, growth stage tech companies, investors, and established institutions.
Made for Knoxville shines the light on the big wins, everyday hustles, and ongoing challenges that our entrepreneurial ecosystem faces in unprecedented times - through an incredible collection of original interview videos, profiles of nearly one hundred entrepreneurs, and original blog articles by Knoxville legend Jack Neely.
What s happening with the Wales team that still hasn t played a match five years after being reformed
England and Scotland are resurrecting their A teams for a game this summer, but there is no sign of the WRU following suit
Shane Williams takes on the French defence for Wales A in 2002, with a young Michael Owen watching on (Image: Huw Evans Agency)
With England and Scotland reintroducing their A sides, thoughts have once again turned to Wales’ own mysterious A team.
It was way back in June 2016 it was announced the Welsh second string was being resurrected after a 14 year absence.
Phil Mendelson buscará otro mandato como presidente del Consejo DC eltiempolatino.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eltiempolatino.com Daily Mail and Mail on Sunday newspapers.
Photo: Kwanchai Lettanapunyaporn/Getty Images
Atlanta-based Florence, maker of software that supports clinical research with remote connectivity and electronic document management, scored $80 million in Series C funding. Insight Partners led the round with participation from Fulcrum Equity Partners, Bee Partners and Flashpoint.
This brings the company s total funding pot to roughly $88 million. It closed its $7.1 million Series B round in 2019.
WHAT IT DOES
The company is focused on decentralized clinical trials. Its main function is helping to connect pharma companies with study sites. Stakeholders are able to tap into the platform to remotely connect to research and collaborate with colleagues on documents, data and workflow.